期刊文献+

10-羟基喜树碱治疗胃肠道肿瘤近期疗效及安全性的Meta分析 被引量:2

Short-Term Efficacy and Safety of 10-Hydroxy-camptothecin Chemotherapy on Gastrointestinal Carcinoma: A Meta-analysis
在线阅读 下载PDF
导出
摘要 目的评价10-羟基喜树碱治疗胃肠道肿瘤的近期临床疗效和安全性.方法电子检索中国学术期刊网全文数据库(1995~2005),MEDLINE(1995~2005)和Cochrane图书馆(2005第1期),并与研究者联系以获得更多相关研究资料.纳入比较10-羟基喜树碱(10-HCPT)或以10-HCPT为主的二联及多联化疗方案治疗胃肠道肿瘤的随机对照试验,比较两组化疗有效率、消化道和血液毒性反应率.由两名评价员独立检索和提取资料并交叉核对,对纳入文献的方法学质量进行评价,数据采用RevMan4.2.2版软件进行统计分析.结果共纳入25个试验,共1 881例患者.Meta分析结果提示:10-HCPT可以显著提高近期大肠癌化疗疗效[OR 1.62,95%CI(1.37,1.92)]和胃癌化疗疗效[OR 1.48,95%CI(1.18,1.85)],其所致消化道严重毒性反应发生率与对照组比较差异无统计学意义[OR 0.96,95%CI(0.62,1.50)],但血液系统严重毒性反应发生率却显著增高[OR 1.27,95%CI(1.02,1.58)].结论现有研究资料显示,10-HCPT可以提高胃肠道肿瘤化疗近期临床疗效,但会增加血液系统严重毒性反应发生率,其在改善预后方面的作用还需要进一步研究. Objective To evaluate the short-term clinical efficacy and safety of 10-Hydroxy-camptothecin (10- HCPT ) chemotherapy on gastrointestinal carcinoma. Methods We searched electronic database including CNKI ( 1995 - 2005 ), MEDLINE ( 1995 - 2005 ) and The Cochrane Library ( Issue 1, 2005 ). More related research data were odtained by cantacting with researchers. Randomized controlled trials of gastrointestinal carcinoma chemotherapy comparing only or including 10-HCPT chemotherapy with normal chemotherapy on efficacy rate, digestive and hematology system toxicity were included. Data related to the clinical outcome were extracted by two reviewers independently. Statistical analysis was performed by using RevMan4. 2.2. Results Twenty-five trials including 1 881 patients met the inclusion criteria. The results of meta-analysis were hsted as follows: 10-HCPT could significantly improve the short-term chemotherapy efficacy for colorectal cancer ( RR. 1.62, 95% CI 1.37 to 1.92) and gastric cancer (RR 1.48, 95% CI 1.18 to 1.85)in chemotherapy curative efficacy in short-term. 10-HCPT induced severe toxicity of lower digestive system(RR. 0.96,95% CI 0.62 to 1.50 ) without statistical significance, while severe toxicity of hematology system was significantly higher than that of control with RR 1.27,95% CI 1.02 to 1.58. Conclusions Current evidence suggests that 10-HCPT can improve hematology system short-term chemotherapy efficacy for gastrointestinal carcinoma and increase the incidence of severe toxicity. Further research is needed to value its influence on the prognosis of gastrointestinal carcinoma.
出处 《中国循证医学杂志》 CSCD 2006年第2期124-130,共7页 Chinese Journal of Evidence-based Medicine
关键词 10-羟基喜树碱 胃肠道肿瘤 META分析 治疗 安全性 10-Hydroxy-camptothecin Gastrointestinal carcinoma Meta-analysis
  • 相关文献

参考文献30

二级参考文献80

共引文献35

同被引文献18

  • 1骆卉妍,李宇红,张力,姜文奇,史艳侠,王峰,何友兼,徐瑞华.CPT-11联合5-FU/CF(FOLFIRI)化疗方案治疗晚期结直肠癌[J].癌症,2007,26(8):905-908. 被引量:4
  • 2Parkin DM,Bray F,Ferlay J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.
  • 3Kurbacher CM,Cree IA.Chemosensitivity testing using microplate adenosine triphosphate-based luminescence measurements[M]//Blumenthal RD.Method in molecular medicine.Chemosensitivity volume 1:in vitro assays.New York:Human Press Inc,2005:101-120.
  • 4Kangas L,Grnroos M,Nieminen AL.Bioluminescence of cellular ATP:a new method for evaluating cytotoxic agents in vitro[J].Med BioL,1984,62(6):338-342.
  • 5Cree IA,Kurbacher CM,Lamont A,et al.A prospective randomized controlled trial of tumour chemosensitivity assay directed chemotherapy versus physicians choice in patients with recurrent platinum-resistant ovarian cancer[J].Anticancer Drugs,2007,18(9):1093-1101.
  • 6Qi CJ,Zhu YL,Qian KQ,et al.In vitro chemosensitivity in breast cancer using ATP-tumor chemosensitivity assay[J].Arch Pharm Res,2009,32 (12):1737-1742.
  • 7Cho YB,Lee WY,Song SY,et al.In vitro chemosensitivity based on depth of invasion in advanced colorectal cancer using ATP-based chemotherapy response assay (ATP-CRA)[J].Eur J Surg Oncol,2009,35(9):951-956.
  • 8Engstrom PF,National Comprehensive Cancer Network.Systemic therapy for advanced or metastatic colorectal cancer:national cmnprehensive cancer network guide-lines for combining anti-vascular endothelial growth factor and anti-epidermal growth factor receptor monoclonal antibodies with chemotherapy[J].Pharmacotherapy,2008,28(11):18-22.
  • 9Mac,Donaid JS. 5 - fluorouracil, doxorubicin and mitomycin (FAM) combination- chemotherapy for advanced gastric cancer[J]. J Anu Intern Med, 1980,93(4):533- 536
  • 10Preusser P,Wilke H,Achterraib W,et al. Phase Ⅱ study with Combination ctoposide Doxorubicin,and cisplatin in Advanced Measurable Gastric Cancer[J]. J Clin Oncol,1989,7(9), 1310 -1317

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部